Skip to main content
Erschienen in: Wiener klinische Wochenschrift 3-4/2018

05.12.2017 | Original Article

Performance of 4 years of population-based mammography screening for breast cancer combined with ultrasound in Tyrol / Austria

verfasst von: Dr. Sabine Geiger-Gritsch, Dr. Martin Daniaux, Univ.Doz. Dr. Wolfgang Buchberger, MSc, Dr. Rudolf Knapp, Assoc.Prof. PD Dr. Willi Oberaigner

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 3-4/2018

Einloggen, um Zugang zu erhalten

Summary

Background

Systems for the delivery of screening mammography vary among countries and these differences can influence screening effectiveness. We evaluated the performance of organized mammography screening for breast cancer combined with ultrasound in Tyrol / Austria, an approach that differs from many other population-based screening programs.

Methods

Data on women aged 40–69 years screened in the period from June 2008 to May 2012 were collected within the framework of an organized screening program. A total of 272,555 invitations were sent to the target population living in Tyrol and 176,957 screening examinations were performed. We analyzed the main performance indicators as defined by European Union (EU) guidelines and some important estimates of harms.

Results

The estimated 2‑year participation rate was 56.9%. As ultrasound is implemented as second-line screening procedure, 76.2% of all women screened underwent supplementary ultrasound. In total 2322 women were recalled for further assessment (13.1 per 1000 screens) and 1351 biopsies were performed (7.6 per 1000 screens). The positive predictive value was 28.2% for assessment and 48.5% for biopsies. The cancer detection rate was 3.7 per 1000 screens and the proportion of all stage II+ screen-detected cancers was 35.5%. The interval cancer rate was 0.33 and 0.47 per 1000 screens in the first and second years, respectively. The estimated cumulative risk for a false positive screening result and an unnecessary biopsy for women following the invitation approach was 21.1% and 9.4%, respectively.

Conclusion

The performance of our population-based screening approach combining mammography and ultrasound is very favorable and potential harm is kept very low compared to other European mammography screening programs for breast cancer.
Literatur
4.
Zurück zum Zitat Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778–86.CrossRef Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778–86.CrossRef
5.
Zurück zum Zitat Anttila A, Koskela J, Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen. 2002;9(4):153–8.CrossRefPubMed Anttila A, Koskela J, Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen. 2002;9(4):153–8.CrossRefPubMed
6.
Zurück zum Zitat Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363(13):1203–10.CrossRefPubMed Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363(13):1203–10.CrossRefPubMed
7.
Zurück zum Zitat Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ. 2005;330(7485):220.CrossRefPubMedPubMedCentral Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ. 2005;330(7485):220.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 2004;42(5):793–806.CrossRefPubMed Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 2004;42(5):793–806.CrossRefPubMed
9.
Zurück zum Zitat Tabar L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF, et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000;38(4):625–51.CrossRefPubMed Tabar L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF, et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000;38(4):625–51.CrossRefPubMed
10.
Zurück zum Zitat Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–92.CrossRefPubMed Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–92.CrossRefPubMed
11.
Zurück zum Zitat Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, editors. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg: Office for Official Publications of the European Communities; 2006. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, editors. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg: Office for Official Publications of the European Communities; 2006.
12.
Zurück zum Zitat Giordano L, von Karsa L, Tomatis M, Majek O, de Wolf C, Lancucki L, et al. Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen. 2012;19(Suppl 1):72–82.CrossRefPubMed Giordano L, von Karsa L, Tomatis M, Majek O, de Wolf C, Lancucki L, et al. Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen. 2012;19(Suppl 1):72–82.CrossRefPubMed
13.
Zurück zum Zitat Oberaigner W, Buchberger W, Frede T, Daniaux M, Knapp R, Marth C, et al. Introduction of organised mammography screening in Tyrol: results of a one-year pilot phase. BMC Public Health. 2011;11:91.CrossRefPubMedPubMedCentral Oberaigner W, Buchberger W, Frede T, Daniaux M, Knapp R, Marth C, et al. Introduction of organised mammography screening in Tyrol: results of a one-year pilot phase. BMC Public Health. 2011;11:91.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Oberaigner W, Daniaux M, Geiger-Gritsch S, Knapp R, Siebert U, Buchberger W. Introduction of organised mammography screening in Tyrol: results following first year of complete rollout. BMC Public Health. 2011;11:673.CrossRefPubMedPubMedCentral Oberaigner W, Daniaux M, Geiger-Gritsch S, Knapp R, Siebert U, Buchberger W. Introduction of organised mammography screening in Tyrol: results following first year of complete rollout. BMC Public Health. 2011;11:673.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000;355(9198):129–34.CrossRefPubMed Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000;355(9198):129–34.CrossRefPubMed
16.
Zurück zum Zitat Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108(11):2205–40. Jun.CrossRefPubMedPubMedCentral Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108(11):2205–40. Jun.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Paci E. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen. 2012;19(Suppl 1):5–13.CrossRefPubMed Paci E. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen. 2012;19(Suppl 1):5–13.CrossRefPubMed
18.
Zurück zum Zitat Smith RA, Duffy SW, Tabar L. Breast cancer screening: the evolving evidence. Oncology. 2012;26(5):471–5, 9–81, 85–6.PubMed Smith RA, Duffy SW, Tabar L. Breast cancer screening: the evolving evidence. Oncology. 2012;26(5):471–5, 9–81, 85–6.PubMed
19.
Zurück zum Zitat Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med. 2014;174(3):448–54.CrossRefPubMed Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med. 2014;174(3):448–54.CrossRefPubMed
21.
Zurück zum Zitat Biller-Andorno N, Juni P. Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med. 2014;22;370(21):1965–7.CrossRef Biller-Andorno N, Juni P. Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med. 2014;22;370(21):1965–7.CrossRef
22.
Zurück zum Zitat Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998–2005.CrossRefPubMed Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998–2005.CrossRefPubMed
23.
Zurück zum Zitat Jorgensen KJ. Mammography screening. Benefits, harms, and informed choice. Dan Med J. 2013;60(4):B4614.PubMed Jorgensen KJ. Mammography screening. Benefits, harms, and informed choice. Dan Med J. 2013;60(4):B4614.PubMed
24.
Zurück zum Zitat Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-cancer screening – viewpoint of the IARC Working Group. N Engl J Med. 2015;372(24):2353–8.CrossRefPubMed Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-cancer screening – viewpoint of the IARC Working Group. N Engl J Med. 2015;372(24):2353–8.CrossRefPubMed
25.
Zurück zum Zitat Hersch J, Jansen J, Irwig L, Barratt A, Thornton H, Howard K, et al. How do we achieve informed choice for women considering breast screening? Prev Med. 2011;53(3):144–6.CrossRefPubMed Hersch J, Jansen J, Irwig L, Barratt A, Thornton H, Howard K, et al. How do we achieve informed choice for women considering breast screening? Prev Med. 2011;53(3):144–6.CrossRefPubMed
26.
Zurück zum Zitat Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311(13):1327–35.CrossRefPubMed Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311(13):1327–35.CrossRefPubMed
27.
Zurück zum Zitat Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH. Informed decision making: what is its role in cancer screening? Cancer. 2004;101(5 Suppl):1214–28.CrossRefPubMed Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH. Informed decision making: what is its role in cancer screening? Cancer. 2004;101(5 Suppl):1214–28.CrossRefPubMed
29.
Zurück zum Zitat StataCorp. Stata statistical software: release 13. College Station: StataCorp LP; 2013. StataCorp. Stata statistical software: release 13. College Station: StataCorp LP; 2013.
30.
Zurück zum Zitat Oberaigner W, Siebert U. Are survival rates for Tyrol published in the Eurocare studies biased? Acta Oncol. 2009;48(7):984–91.CrossRefPubMed Oberaigner W, Siebert U. Are survival rates for Tyrol published in the Eurocare studies biased? Acta Oncol. 2009;48(7):984–91.CrossRefPubMed
31.
Zurück zum Zitat Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, et al. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen. 2012;19(Suppl 1):57–66.CrossRefPubMed Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, et al. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen. 2012;19(Suppl 1):57–66.CrossRefPubMed
32.
Zurück zum Zitat Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Bohm-Velez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151–63.CrossRefPubMedPubMedCentral Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Bohm-Velez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151–63.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Buchberger W, Niehoff A, Obrist P, DeKoekkoek-Doll P, Dunser M. Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MR. 2000;21(4):325–36.CrossRefPubMed Buchberger W, Niehoff A, Obrist P, DeKoekkoek-Doll P, Dunser M. Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MR. 2000;21(4):325–36.CrossRefPubMed
34.
Zurück zum Zitat Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225(1):165–75.CrossRefPubMed Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225(1):165–75.CrossRefPubMed
35.
Zurück zum Zitat Gartlehner G, Thaler KJ, Chapman A, Kaminski A, Berzaczy D, van Noord MG, et al. Adjunct ultrasonography for breast cancer screening in women at average risk: a systematic review. Int J Evid Based Healthc. 2013;11(2):87–93.CrossRefPubMed Gartlehner G, Thaler KJ, Chapman A, Kaminski A, Berzaczy D, van Noord MG, et al. Adjunct ultrasonography for breast cancer screening in women at average risk: a systematic review. Int J Evid Based Healthc. 2013;11(2):87–93.CrossRefPubMed
36.
Zurück zum Zitat Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, et al. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med. 2015;162(3):157–66.CrossRefPubMedPubMedCentral Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, et al. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med. 2015;162(3):157–66.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Harvey SC, Geller B, Oppenheimer RG, Pinet M, Riddell L, Garra B. Increase in cancer detection and recall rates with independent double interpretation of screening mammography. Ajr Am J Roentgenol. 2003;180(5):1461–7.CrossRefPubMed Harvey SC, Geller B, Oppenheimer RG, Pinet M, Riddell L, Garra B. Increase in cancer detection and recall rates with independent double interpretation of screening mammography. Ajr Am J Roentgenol. 2003;180(5):1461–7.CrossRefPubMed
38.
Zurück zum Zitat Buist DS, Anderson ML, Haneuse SJ, Sickles EA, Smith RA, Carney PA, et al. Influence of annual interpretive volume on screening mammography performance in the United States. Radiology. 2011;259(1):72–84.CrossRefPubMedPubMedCentral Buist DS, Anderson ML, Haneuse SJ, Sickles EA, Smith RA, Carney PA, et al. Influence of annual interpretive volume on screening mammography performance in the United States. Radiology. 2011;259(1):72–84.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Rawashdeh MA, Lee WB, Bourne RM, Ryan EA, Pietrzyk MW, Reed WM, et al. Markers of good performance in mammography depend on number of annual readings. Radiology. 2013;269(1):61–7.CrossRefPubMed Rawashdeh MA, Lee WB, Bourne RM, Ryan EA, Pietrzyk MW, Reed WM, et al. Markers of good performance in mammography depend on number of annual readings. Radiology. 2013;269(1):61–7.CrossRefPubMed
40.
Zurück zum Zitat Cornford E, Reed J, Murphy A, Bennett R, Evans A. Optimal screening mammography reading volumes; evidence from real life in the East Midlands region of the NHS Breast Screening Programme. Clin Radiol. 2011;66(2):103–7.CrossRefPubMed Cornford E, Reed J, Murphy A, Bennett R, Evans A. Optimal screening mammography reading volumes; evidence from real life in the East Midlands region of the NHS Breast Screening Programme. Clin Radiol. 2011;66(2):103–7.CrossRefPubMed
41.
Zurück zum Zitat Brennan PC, Soh BP. The challenge of assessing reader performance in mammography. Clin Radiol. 2012;67(2):192.CrossRefPubMed Brennan PC, Soh BP. The challenge of assessing reader performance in mammography. Clin Radiol. 2012;67(2):192.CrossRefPubMed
42.
Zurück zum Zitat Duncan KA, Scott NW. Is film-reading performance related to the number of films read? The Scottish experience. Clin Radiol. 2011;66(2):99–102.CrossRefPubMed Duncan KA, Scott NW. Is film-reading performance related to the number of films read? The Scottish experience. Clin Radiol. 2011;66(2):99–102.CrossRefPubMed
43.
Zurück zum Zitat Moss SM, Blanks RG, Bennett RL. Is radiologists’ volume of mammography reading related to accuracy? A critical review of the literature. Clin Radiol. 2005;60(6):623–6.CrossRefPubMed Moss SM, Blanks RG, Bennett RL. Is radiologists’ volume of mammography reading related to accuracy? A critical review of the literature. Clin Radiol. 2005;60(6):623–6.CrossRefPubMed
44.
Zurück zum Zitat Geiger-Gritsch S, Martini C, Holzner B, Oberaigner W. Befragung von Teilnehmerinnen und Nicht-Teilnehmerinnen des Mammographie Screening Programms Tirol im Jahr. 2013. Geiger-Gritsch S, Martini C, Holzner B, Oberaigner W. Befragung von Teilnehmerinnen und Nicht-Teilnehmerinnen des Mammographie Screening Programms Tirol im Jahr. 2013.
45.
Zurück zum Zitat Hofvind S, Sorum R, Thoresen S. Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program. Acta Oncol. 2008;47(2):225–31.CrossRefPubMed Hofvind S, Sorum R, Thoresen S. Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program. Acta Oncol. 2008;47(2):225–31.CrossRefPubMed
Metadaten
Titel
Performance of 4 years of population-based mammography screening for breast cancer combined with ultrasound in Tyrol / Austria
verfasst von
Dr. Sabine Geiger-Gritsch
Dr. Martin Daniaux
Univ.Doz. Dr. Wolfgang Buchberger, MSc
Dr. Rudolf Knapp
Assoc.Prof. PD Dr. Willi Oberaigner
Publikationsdatum
05.12.2017
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 3-4/2018
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-017-1293-9

Weitere Artikel der Ausgabe 3-4/2018

Wiener klinische Wochenschrift 3-4/2018 Zur Ausgabe

MUW researcher of the month

MUW researcher of the month